Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: Effect of genetic background

Inflammatory Bowel Diseases

Volumn 19, Issue 6, 2013, Pages 1238-1244

  Reingold, Laura ^a   Rahal, Kinan ^a   Schmiedlin Ren, Phyllissa ^a   Rittershaus, Ahren C ^b   Bender, Diane ^a   Owens, Scott R ^b   Adler, Jeremy ^a   Zimmermann, Ellen M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Animal models; Crohn's Disease; IBD; Mouse; NOD2; PGPS

Indexed keywords

HUMAN SERUM ALBUMIN; PEPTIDOGLYCAN POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; LAPAROTOMY; MOUSE; MOUSE STRAIN; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CECUM; COLITIS; CROHN DISEASE; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; ILEITIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; PEPTIDOGLYCAN; PEYER'S PATCHES; RATS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84879212560     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31828132b4     Document Type: Article

References (29)

1. Hibi T, Ogata H, Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol. 2002;37:409-417.
2. Hoffmann JC, Pawloski NN, Kuhl AA, et al. Animal models of inflammatory bowel disease: an overview. Pathobiology. 2002-2003;70: 121-130.
3. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev. 2007;59:1073-1083.
4. Koboziev I, Karlsson F, Zhang S, et al. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis. 2011; 17:1229-1245.
5. Sartor RB, Cromartie WJ, Powell DW, et al. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology. 1985;89:587-595.
6. Rahal K, Schmiedlin-Ren P, Adler J, et al. Resveratrol has anti-inflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease. Inflamm Bowel Dis. 2012;18:613-623.
7. Sartor RB, Bond TM, Schwab JH. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect Immun. 1988;56:2101-2108.
8. Sartor RB, Bender DE, Allen JB, et al. Chronic experimental enterocolitis and extraintestinal inflammation are T lymphocyte dependent (Abstract). Gastroenterology. 1993;104:A775.
9. Sartor RB, Herfarth H, Van Tol EAF. Bacterial cell wall polymer-induced granulomatous inflammation. Methods. 1996;9:233-247.
10. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem. 2002;278: 5509-5512.
11. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002;122:867-874.
12. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194-199.
13. Park JH, Kim YG, McDonald C, et al. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol. 2007;178:2380-2386.
14. Kobayashi K, Chamaillard M, Ogura Y, et al. Nod2 dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307: 731-734.
15. Zimmermann EM, Sartor RB, McCall RD, et al. Insulinlike growth factor I and interleukin 1b messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology. 1993;105:399-409.
16. Moolenbeek C, Ruitenberg J. The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab Anim. 1981;15:57-59.
17. Adler J, Rahal K, Swanson SD, et al. Anti-tumor necrosis factor a prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease. Inflamm Bowel Dis. 2013;19: 683-690.
18. Garcia P, Schmiedlin-Ren P, Mathias JS, et al. Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 2012;302: G326-G335.
19. Rieder F, Kessler S, Sans M, et al. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol. 2012;303:G786-G801.
20. Pucilowska J, Williams KL, Lund PK. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol. 2000;279:G653-G659.
21. Dickinson GS, Piccone H, Sun G, et al. Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection. Infect Immun. 2010;78:4579-4588.
22. Kim YG, Shaw MH, Warner N, et al. Cutting edge: Crohn's diseaseassociated Nod2 mutation limits production of proinflammatory cytokines to protect the host from Enterococcus faecalis-induced lethality. J Immunol. 2011;187:2849-2852.
23. Geddes K, Rubino S, Streutker C, et al. Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect Immun. 2010;78: 5107-5115.
24. Kato F, Nomura M, Nakamura K. Arthritis in mice induced by a single immunisation with collagen. Ann Rheum Dis. 1996;55:535-539.
25. Poltorak A, He X, Smirnova I, et al. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282: 2085-2088.
26. Davis RR, Newlander JK, Ling X, et al. Genetic basis for susceptibility to noise-induced hearing loss in mice. Hear Res. 2001;155:82-90.
27. Xie C, Sharma R, Wang H, et al. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol. 2004;172:5047-5055.
28. Fang Y, Zhao L, Yan F. Chemokines as novel therapeutic targets in autoimmune thyroiditis. Recent Pat DNA Gene Seq. 2010;4:52-57.
29. Yoshimura T, Ebihara S. Decline of circadian photosensitivity associated with retinal degeneration in CBA/J-rd/rd mice. Brain Res. 1998;779:188-193.